Posters and Presentations Archives | Aldeyra Therapeutics, Inc.

Posters and Presentations

Podium Presentation of Dry Eye Disease 2b Clinical Trial of Reproxalap (2019 ARVO Annual Meeting) – May 2019

PDF (2.47 MB)

May 2019

Posters and Presentations

Aldeyra Therapeutics Announces Positive Top-Line Results from the Phase 3 ALLEVIATE Trial in Allergic Conjunctivitis – March 2019

PDF (1.44 MB)

March 2019

Posters and Presentations

2019 Research & Development Day with Updates on Research Programs – February 2019

PDF (6.72 MB)

February 2019

Posters and Presentations

Aldeyra Therapeutics Announces Positive Results from Phase 2b Dry Eye Disease Clinical Trial – September 2018

PDF (3.28 MB)

September 2018

Posters and Presentations

Poster Presentation of ADX-103 Activity in Model of Diabetic Macular Edema (Association for Research in Vision and Ophthalmology 2018 Annual Meeting) – May 2018

PDF (241.60 KB)

May 2018

Posters and Presentations

Poster Presentation of Allergic Conjunctivitis Phase 2b Clinical Trial of Reproxalap (Association for Research in Vision and Ophthalmology 2018 Annual Meeting) – May 2018

PDF (238.67 KB)

May 2018

Posters and Presentations

Poster Presentation of Reproxalap and ADX-103 Activity in Models of Pan-Ocular and Retinal Diseases (Association for Research in Vision and Ophthalmology 2018 Annual Meeting) – May 2018

PDF (633.49 KB)

May 2018

Posters and Presentations

Podium Presentation of Phase 2a Dry Eye Disease Clinical Trial Results (Association for Research in Vision and Ophthalmology 2018 Annual Meeting) – April 2018

PDF (724.63 KB)

April 2018

Posters and Presentations

Podium Presentation of Statistical Non-inferiority of Reproxalap to Corticosteroid Therapy in Noninfectious Anterior Uveitis (2017 American Uveitis Society Fall Meeting) – November 2017

PDF (599.41 KB)

November 2017

Posters and Presentations

Poster Presentation of Reproxalap Activity in Model of Succinic Semi-Aldehyde Dehydrogenase Deficiency (American Society of Human Genetics 2017 Annual Meeting) – October 2017

PDF (703.87 KB)

October 2017